Best supportive care for patients with primary progressive multiple sclerosis (PPMS) in Germany prior to ocrelizumab treatment: Final results from the RETRO PPMS study
This analysis uncovers severe BSC deficits for many debilitating PPMS symptoms. There is still a large unmet need for innovative multidisciplinary care concepts and improvements in neurological primary and secondary care.
Authors
- Jost Leemhuis
- Stefanie Hieke‐Schulz
- Herbert Schreiber (ORCID: https://orcid.org/0000-0002-4755-492X)
- Iris‐Katharina Penner (ORCID: https://orcid.org/0000-0002-6746-1034)
- Tanja Maier (ORCID: https://orcid.org/0000-0003-0585-4796)
- Tjalf Ziemssen (ORCID: https://orcid.org/0000-0001-8799-8202)
Institutions
- University of Bern (CH)
- University Hospital of Bern (CH)
- Roche Pharma AG (Germany) (DE)
- University Hospital Carl Gustav Carus (DE)
Publication Details
- Journal
- Journal of Central Nervous System Disease
- Published
- 2024-10-23
- DOI
- https://doi.org/10.1177/11795735241296001
- Citations
- 2
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.85